Stay updated on ACTIV-5 / BET-B COVID-19 Clinical Trial
Sign up to get notified when there's something new on the ACTIV-5 / BET-B COVID-19 Clinical Trial page.

Latest updates to the ACTIV-5 / BET-B COVID-19 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedGlossary toggle controls (Show glossary / Hide glossary) were added to the page UI. The update log text was revised to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check19 days agoChange DetectedA minor site revision update is shown (v3.3.4 vs v3.3.3); no study details or eligibility information appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedLocations section added with a comprehensive list of study sites across multiple US states and international locations (including Gyeonggi-do and Jongno-gu). The prior revision removed the HHS Vulnerability Disclosure and the location listings.SummaryDifference2%

- Check68 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not be about the study. The revision label has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check75 days agoChange DetectedRemoved the general government funding notice that warned information may not be up to date and that some site operations could be affected, which previously directed users to cc.nih.gov and opm.gov for status updates; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check98 days agoChange DetectedThe Locations section was updated to add new study sites and adjust existing ones for the BET-B trial.SummaryDifference0.2%

Stay in the know with updates to ACTIV-5 / BET-B COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTIV-5 / BET-B COVID-19 Clinical Trial page.